Exor lifts stake in Philips to 18.7%, SEC filing shows
Exor NV , the investment arm of Italy's Agnelli family, has increased its stake in health technology company Philips to 18.7% ...
Koninklijke Philips: Upgrade To Buy Despite Weak Demand From China
Koninklijke Philips tackles challenges in China while focusing on AI and cost-cutting. Find out why PHG stock is a buy with ...
The Sports Rush14d
Kendrick Perkins Recalls JJ Redick’s “Didn’t Sleep for 2 Days” Statement, Shows Excitement for Battle With Joe Mazzulla and Celtics
Both Mazzulla and Redick are the picture-perfect definition of a basketball sicko. They eat, breathe, and sleep basketball. Redick has made waves through the league by shining in his first year as a ...
Sportskeeda15d
"Thinking I might die in my sleep"- Jung Hae-in recalls hilarious camping story with 88-liners Ahn Bo-hyun, Kim Soo Hyun, & others
Four guys shivering together. That freezing night, around the campfire, thinking i might die in my sleep." He said that was when his survival instinct kicked in, prompting him to urge his three ...
Endovascular Today16d
Philips Recalls, Removes, and Discontinues Distribution of Tack Endovascular System
The FDA recall notification advised that all customers should stop using the Tack endovascular system immediately and that Philips will no longer distribute the system for use. According to the ...
Modern Healthcare17d
FDA labels Philips' recall of Tack Endovascular Systems a Class I
The Food and Drug Administration has labeled a recall of Philips’ Tack Endovascular Systems as a Class l, which is the most serious kind of recall. There have been 20 reported injuries and no ...
medtechdive17d
Philips pulls endovascular implant from market after 20 injuries
Philips stopped selling an implant used to repair damaged arteries after reports of 20 injuries and some devices needing to be removed. The Food and Drug Administration said in a Monday recall notice ...
FierceBiotech18d
FDA elevates endovascular recall as Philips pulls Tack implant from the market
Philips is pulling from the market an implant designed to help repair the interior of damaged blood vessels following a serious product recall. The company’s Tack endovascular system includes a ...
Yahoo Finance18d
Philips pulls endovascular implant from market after FDA Class I recall tag
Philips will no longer sell its Tack endovascular system in the US following a Class I recall by the US Food and Drug Administration (FDA). Class I is the most serious designation for a recall ...
Medical Device Network18d
Philips pulls endovascular implant from market after FDA Class I recall tag
Class I is the most serious designation for a recall issued by the FDA. Image credit: Shutterstock / OleksSH. Philips will no longer sell its Tack endovascular system in the US following a Class I ...
MassDevice18d
Philips discontinues Tack endovascular system sales after serious recall
[Image from Philips] The FDA has deemed a recall of the Philips (NYSE: PHG) + Tack endovascular system Class I, the most serious kind. This recall involves removing devices from use and sale.
TCTMD19d
Philips Recalls Tack Endovascular Systems and Stops Distribution
Philips is recalling the Tack endovascular system because of what it says are user challenges that have led to additional interventions needed to retrieve or remove the implant. The US Food and Drug ...